Trends in the in-hospital treatment of acute myocardial infarction between 1984 and 1993 - The Halifax County MONICA Project

Canadian Journal of Cardiology

Volumn 16, Issue 5, 2000, Pages 596-603

  Gregor, Ronald D ^a   Bata, Iqbal R ^a   Brownell, Brenda ^a   Wolf, Hermann K ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Drugs; Epidemiology; Myocardial infarction; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOTONIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CANADA; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; FATALITY; FEMALE; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; DIAGNOSIS, DIFFERENTIAL; DRUG UTILIZATION; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; NOVA SCOTIA; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYNDROME; THROMBOLYTIC THERAPY;

EID: 0034111892     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bata IR, Gregor RD, Eastwood BJ, Wolf HK. Trends in the incidence of acute myocardial infarction between 1984 and 1993 -The Halifax County MONICA Project. Can J Cardiol 2000;16:589-95.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-60.
3. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
4. Domanski MJ, Exner DV, Borkowf CB, Geller NL, Rosenberg Y, Pfeffer MA. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol 1999;33:598-604.
5. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. Circulation 1998;97:2202-12.
6. Huckell VF, Bernstein V, Cairns JA, et al. Angiotensin-converting enzyme inhibition in myocardial infarction - Part 1: Clinical data. Can J Cardiol 1997;13:161-9.
7. Gruppo Italiano per lo Studio della Streptochinast nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-402.
8. Hartzler GO, Rutherford BD, McConahay DR, et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983;106:965-73.
9. O'Neill W, Timmis GC, Bourdilbn PD, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 1986;314:812-8.
10. O'Neill WW, Weintraub R, Grines CL, et al. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation 1992;86:1710-7.
11. WHO MONICA Project. MONICA Manual. (March 31, 1999) http://www.ktl.fi/publications/monica/manual/index.htm.
12. Bata IR, Eastwood BJ, Gregor RD, et al. Decreasing mortality from acute myocardial infarctions: effect of attack rates and case severity. J Clin Epidemiol 1997;50:787-91.
13. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
14. Mähönen M, Tolonen H, Kuulasmaa K, Tunstall-Pedoe H, Amouyel P. Quality asessment of coronary event registration data in the WHO MONICA Project. (January 1999) http://www.ktl.fi/publications/monica/coreqa/coreqa.htm.
15. World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification Index. Veivet: WHO Collaborating Centre for Drug Statistics Methodology, 1993.
16. Daley J, Jencks S, Draper D, Lenhart G, Thomas N, Walker J. Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. JAMA 1988;260:3617-24.
17. Buck S. A method of estimation of missing values in multivariate data suitable for use with electronic computer. J R Stat Soc 1960;B22:302-6.
18. Gregor RD, Bata IR, Eastwood BJ, Wolf HK. Ten-year trends of heart disease risk factors in the Halifax County MONICA population. Can J Cardiol 1998;14:1017-24.
19. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med 1999;341:226-32.
20. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM, for the National Registry of Myocardial Infarction 2 Participants. Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999;341:217-25.
21. Mahon NG, Codd MB, O'Rorke C, Egan B, McCann HA, Sugrue DD. Management and outcome of acute myocardial infarction in older patients in the thrombolytic era. J Am Geriatr Soc 1999;47:291-4.
22. Miettinen H, Salomaa V, Ketonen M, Niemela M, Immonen-Raiha P, Mähönen M. Trends in the treatment of patients with myocardial infarction and coronary revascularization procedures in Finland during 1986-92: the FINMONICA Myocardial Infarction Register Study. J Intern Med 1999;245:11-20.
23. Bourquin MG, Wietlisbach V, Rickenbach M, Ferret F, Paccaud F. Time trends in the treatment of acute myocardial infarction in Switzerland from 1986 to 1993: do they reflect the advances in scientific evidence from clinical trials? J Clin Epidemiol 1998;51:723-32.
24. Thompson PL, Parsons RW, Jamrozik K, Hockey RL, Hobbs MS, Broadhurst RJ. Changing patterns of medical treatment in acute myocardial infarction. Observations from the Perth MONICA Project 1984-1990. Med J Aust 1992;157:87-92.
25. Heller RF, Dobson AJ, Alexander HM, Steele PL, Malcolm JA. Changes in drug treatment and case fatality of patients with acute myocardial infarction. Observations from the Newcastle MONICA Project, 1984/1985 to 1988/1990. Med J Aust 1992;157:83-6.
26. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77.
27. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
28. Ertl G, Kloner RA, Alexander RW, Braunwald E. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation 1982;65:40-8.
29. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-6.
30. Hjemdahl-Monsen CE, Lewis HD, Cairns J, Chesebro JH, Fuster V. Role of antithrombotic therapy in unstable angina, myocardial infarction and sudden death. J Am Coll Cardiol 1986;8(6Suppl B):67B-75B.
31. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986;ii:57-66.
32. Roberts R. Review of calcium antagonist trials in acute myocardial infarction. Clin Cardiol 1989; 12(7 Suppl 3):III41-7.
33. Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Br Heart J 1986;56:400-13.
34. The effect of diltiazem on mortality and reinfarction after myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group. N Engl J Med 1988;319:385-92.
35. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
36. Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988;ii:525-30.
37. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 1989;320:618-27.